Ferrlecit and Remicade drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ferrlecit (sodium ferric gluconate complex) and Remicade (infliximab). Common drug interactions include arrhythmia among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Ferrlecit and Remicade. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Ferrlecit?

Ferrlecit has active ingredients of sodium ferric gluconate complex. eHealthMe is studying from 2,376 Ferrlecit users. Check the latest studies of Ferrlecit.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.

On Jul, 09, 2026

21 people who take Ferrlecit and Remicade together, and have interactions are studied.

Ferrlecit and Remicade drug interactions.

What are the common drug interactions of Ferrlecit and Remicade, by gender? *:

female:

Arrhythmia (irregular heartbeat)
Drug ineffective
Anaphylactic reaction (serious allergic reaction)
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Diarrhoea
Hypersensitivity
Hypotension (abnormally low blood pressure)
Nausea (feeling of having an urge to vomit)
Perirectal abscess
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

male:

Drug ineffective
Anal abscess
Infusion related reaction
Iron deficiency anaemia
Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
Metastases to liver (cancer spreads to liver)
Metastases to peritoneum (cancer spreads to peritoneum)
Neuroendocrine carcinoma (cancer tumour that arise from cells of the endocrine (hormonal) and nervous systems)
Rectal cancer (cancer of rectum)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)

What are the common drug interactions of Ferrlecit and Remicade, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Drug ineffective

10-19:

Dyspnoea (difficult or laboured respiration)
Erythema (redness of the skin)
Hypersensitivity
Infusion related reaction
Pruritus (severe itching of the skin)
Swelling face
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Perirectal abscess
Small intestinal obstruction (blockage in small intestine)

20-29:

Anal abscess
Burnout syndrome (problems related to life-management difficulty, but not considered a ""disorder)
Cachexia (loss of weight)
Cholangitis sclerosing (infection and obstruction of bile duct)
Dehydration (dryness resulting from the removal of water)
Dermatitis allergic (inflammation of the skin due allergic reaction)
Diarrhoea haemorrhagic (bloody diarrhoea)
Drug ineffective
Infection
Iron deficiency anaemia

30-39:

n/a

40-49:

Liver abscess (pus in liver)
Bacillus infection
Escherichia infection (bacterial infection by escherichia coli)
Klebsiella infection
Sepsis (a severe blood infection that can lead to organ failure and death)
Septic shock (shock due to blood infection)
Uterine fibroids (benign growths of the muscle inside the uterus)

50-59:

Infusion related reaction
Arrhythmia (irregular heartbeat)
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Flushing (the warm, red condition of human skin)
Headache (pain in head)
Hypertensive crisis

60+:

Haemorrhage (bleeding)
Heparin-induced thrombocytopenia
Influenza
Wrist fracture

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 6 people, 28.57%
Iron Deficiency Anaemia: 2 people, 9.52%
Anaemia (lack of blood): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Ferrlecit and Remicade?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously